Earnings & Reporting

Quantum firm IonQ shatters revenue goals with $130M in 2025 and moves to acquire a chip foundry, signaling an aggressive push to own the quantum stack.

XPEL reports a massive 50% jump in Q4 net income, yet shares tumble as a revenue miss and a cautious 2026 outlook overshadow the impressive profit growth.

With its new HAE drug EKTERLY® smashing revenue forecasts, KalVista heads to key conferences where investors will scrutinize its path to profitability.

Avista posts strong utility earnings but faces hurdles from investment losses and a key customer departure, unveiling a multi-billion dollar grid plan.

Industry leaders ILMC and Pollstar are launching a major conference in Abu Dhabi, cementing the region's status as a burgeoning global entertainment hub.

With strong earnings but software revenue questions, F5's upcoming investor presentation will be closely watched for its AI strategy and security roadmap.

Vow ASA reports record Q4 revenues but shifts strategy to focus on its booming maritime sector, following major write-downs in its industrial division.

The life sciences giant's significant dividend hike underscores its robust financial health and commitment to growth, even as it pursues major acquisitions.

Amid fluctuating NCLEX pass rates, UWorld launches an intensive three-day review designed to boost student success and ease the burden on nursing faculty.

Tradewinds Universal aims to consolidate the fragmented $8B adult club scene with Peppermint Hippo, but regulatory hurdles and market risks loom large.

The Chicago-style chain posts declining same-store sales and a 40% drop in annual profit, pinning turnaround hopes on a new CEO and strategic slowdown.

Leaving the volatile crypto world behind, Cipher Digital is raising billions to build massive data centers for tech giants like AWS and Google.

Hunt Energy Network acquires the massive Fort Duncan battery, boosting its Texas portfolio to 420MW and signaling an aggressive expansion in the booming ERCOT market.

As Ring Energy preps its Q4 results, investors eye debt reduction, cost control, and 2026 strategy amid a challenging Permian market.

Apellis Pharmaceuticals reports its first profitable year on strong SYFOVRE and EMPAVELI sales, but faces pressure to maintain momentum amid competition.

A new report shows patients are rejecting 'overdone' looks for subtle, strategic care, driven by Ozempic, menopause, and a desire for authenticity.

Life Time posts record 2025 earnings and a 230% Q4 profit surge, announcing a $500M share buyback and an aggressive expansion of its 'athletic country clubs'.

Scotiabank reports a strong start to 2026, with adjusted earnings beating forecasts as international divestitures and domestic growth signal a new focus.

Drilling at the Tesorito deposit has intersected a potential high-grade feeder zone, suggesting a much larger and richer system than previously modeled.

After a challenging year, iGaming affiliate Gentoo Media posts record Q4 profits, signaling a successful pivot to a leaner model ahead of a key refinancing.